RECOMBIVAX HB
Hepatitis B surface antigen (recombinant) · Hepatitis B
Health Canada DIN 02561476. Check the product and formulation on your record before using a schedule.
Plan doses for this product →At a glance
- Brand
- RECOMBIVAX HB
- DIN
02561476- Vaccine
- Hepatitis B surface antigen (recombinant)
- Presentation
- 5 mcg / 0.5 mL · solution · intramuscular · birth to 19 years
- Live vaccine
- No
Age and suitability depend on the product, the person and the reason for vaccination. Use the planner for a starting point and confirm with the Care365 clinical team or doctor.
Official product information
Use the DIN to confirm this exact product in Health Canada's Drug Product Database.
Read product monograph (PDF) ↗
A listed product may not be stocked or publicly funded.
Dose schedules involving this product
These are Canadian Immunization Guide schedules associated with this DIN. The right schedule depends on age, health, prior doses and reason for vaccination.
| Schedule | Doses | Who it applies to |
|---|---|---|
| Hepatitis B — standard three-dose series Standard hepatitis B series at months 0, 1 and 6. | 3 doses | Minimum intervals: 4 weeks between doses 1 and 2, 2 months between doses 2 and 3, and 4 months between doses 1 and 3. The age-appropriate product and dose are chosen by the Care365 clinical team; blood testing after the series is needed for some people. |
Pregnancy and breastfeeding
Family guidance on pregnancy: Recommended for people without immunity who are at high risk of exposure.
Family guidance on breastfeeding: Use if indicated.
This guidance applies to the vaccine family. Confirm this product's details in the monograph and with your clinician. Immunization in pregnancy and breastfeeding: Canadian Immunization Guide — Chapter updated August 2026.
Sources and next steps
- Hepatitis B vaccines: Canadian Immunization Guide — Chapter revised March 2017 · erratum May 2022
- Health Canada product record
General information only. A suggested date is not an appointment or a prescription; the Care365 clinical team or doctor confirms what you need. Clinical rules reviewed on 2026-09-27.
Review with Care365